Viewing Study NCT00405756


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-05-14 @ 9:09 PM
Study NCT ID: NCT00405756
Status: COMPLETED
Last Update Posted: 2017-01-11
First Post: 2006-11-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
Sponsor: Celgene Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Newly Diagnosed Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Newly Diagnosed Multiple Myeloma View
None Celgene View
None CC-5013 View
None Revlimid View
None Lenalidomide View
None Melphalan View
None Prednisone View
None Elderly View